<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>39</volume><submitter>Demaret T</submitter><pubmed_abstract>An 11-month-old girl with severe acidosis, lethargy and vomiting, was diagnosed with holocarboxylase synthetase deficiency. She received biotin and was stable until age 8 years when vomiting, severe acidosis, hypoglycemia, and hyperammonemia developed. Management with intravenous glucose aiming to stimulate anabolism led to hyperglycemic ketoacidosis. Insulin therapy rapidly corrected biochemical parameters, and clinical status improved. We propose that secondary Krebs cycle disturbances affecting pancreatic beta cells impaired glucose-stimulated insulin secretion, resulting in insulinopenia.</pubmed_abstract><journal>Molecular genetics and metabolism reports</journal><pagination>101073</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10973194</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Insulin therapy in acute decompensation of holocarboxylase synthetase deficiency with hyperglycemia and ketoacidosis.</pubmed_title><pmcid>PMC10973194</pmcid><pubmed_authors>Delrue MA</pubmed_authors><pubmed_authors>Mitchell GA</pubmed_authors><pubmed_authors>Demaret T</pubmed_authors><pubmed_authors>Joyal JS</pubmed_authors><pubmed_authors>Parente F</pubmed_authors><pubmed_authors>Karalis A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Insulin therapy in acute decompensation of holocarboxylase synthetase deficiency with hyperglycemia and ketoacidosis.</name><description>An 11-month-old girl with severe acidosis, lethargy and vomiting, was diagnosed with holocarboxylase synthetase deficiency. She received biotin and was stable until age 8 years when vomiting, severe acidosis, hypoglycemia, and hyperammonemia developed. Management with intravenous glucose aiming to stimulate anabolism led to hyperglycemic ketoacidosis. Insulin therapy rapidly corrected biochemical parameters, and clinical status improved. We propose that secondary Krebs cycle disturbances affecting pancreatic beta cells impaired glucose-stimulated insulin secretion, resulting in insulinopenia.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-04T19:12:29.47Z</modification><creation>2025-04-04T19:12:29.47Z</creation></dates><accession>S-EPMC10973194</accession><cross_references><pubmed>38550975</pubmed><doi>10.1016/j.ymgmr.2024.101073</doi></cross_references></HashMap>